GT Biopharma
Stock Forecast, Prediction & Price Target
GT Biopharma Financial Estimates
GT Biopharma Revenue Estimates
GT Biopharma EBITDA Estimates
GT Biopharma Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $13.5M Low: $13.5M High: $13.5M avg. 0% | Avg: $9.7M Low: $9.7M High: $9.7M avg. -28.14% | Avg: $67.7M Low: $67.7M High: $67.7M avg. 597.93% | |
Net Income
% change YoY
| $-58.69M N/A | $-20.50M 65.06% | $-7.59M 62.94% | Avg: $-25.87M Low: $-25.87M High: $-25.87M avg. -240.61% | Avg: $-36.79M Low: $-36.79M High: $-36.79M avg. -42.18% | Avg: $-31.13M Low: $-31.13M High: $-31.13M avg. 15.38% | |
EBITDA
% change YoY
| $-57.47M N/A | $-20.96M 63.52% | $5.97M 128.51% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
EPS
% change YoY
| -$62.54 N/A | -$19.3 69.13% | -$5.64 70.77% | Avg: -$19.2 Low: -$19.2 High: -$19.2 avg. -240.42% | Avg: -$27.3 Low: -$27.3 High: -$27.3 avg. -42.18% | Avg: -$23.1 Low: -$23.1 High: -$23.1 avg. 15.38% | |
Operating Expenses
% change YoY
| $57.51M N/A | $21.25M -63.04% | $13.57M -36.13% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is GT Biopharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -89.13% in 2025-2027.
We have gathered data from N/A analysts. Their low estimate is -25.87M, average is -25.87M and high is -25.87M.
What is GT Biopharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 189.92% in 2025-2027.
We have gathered data from N/A analysts. Their low revenue estimate is $13.5M, average is $13.5M and high is $13.5M.
What is GT Biopharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -89.07% in 2025-2027.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$19.2, average is -$19.2 and high is $-19.2.